Status:
COMPLETED
Antifungal Potential of Moringa Olifera Against Otomycosis
Lead Sponsor:
Deraya University
Collaborating Sponsors:
Minia University
Conditions:
Otomycosis
Eligibility:
All Genders
20-50 years
Phase:
EARLY_PHASE1
Brief Summary
patients with Otomycosis were recognized by an ENT specialist. 20 patients were distributed randomly into two groups. The first group will be treated with Nystatin ear drops twice daily. The second gr...
Detailed Description
Inclusion criteria: (1) Otomycosis . Exclusion criteria: 1. tympanic membrane perforation; 2. concurrent immune suppression, 3. and concurrent bacterial infection.
Eligibility Criteria
Inclusion
- Otomycosis
- ear inflammation
Exclusion
- tympanic membrane perforation
- concurrent immune suppression,
- concurrent bacterial infection.
Key Trial Info
Start Date :
February 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04768829
Start Date
February 18 2021
End Date
December 1 2021
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soad A. Mohamad
Minya, Minya Governorate, Egypt, 05673